4-52038236-AGCCGCCGCC-AGCCGCC
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP6BS1
The NM_000232.5(SGCB):c.21_23delGGC(p.Ala8del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000435 in 1,131,814 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00043 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SGCB
NM_000232.5 disruptive_inframe_deletion
NM_000232.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.16
Genes affected
SGCB (HGNC:10806): (sarcoglycan beta) This gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 4-52038236-AGCC-A is Benign according to our data. Variant chr4-52038236-AGCC-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 978759.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.000435 (492/1131814) while in subpopulation SAS AF= 0.00339 (117/34470). AF 95% confidence interval is 0.00289. There are 0 homozygotes in gnomad4_exome. There are 290 alleles in male gnomad4_exome subpopulation. This position pass quality control queck.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCB | ENST00000381431.10 | c.21_23delGGC | p.Ala8del | disruptive_inframe_deletion | 1/6 | 1 | NM_000232.5 | ENSP00000370839.6 | ||
SGCB | ENST00000506357.5 | n.6_8delGGC | non_coding_transcript_exon_variant | 1/5 | 5 | ENSP00000421235.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 150682Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
150682
Hom.:
Cov.:
32
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00408 AC: 152AN: 37246Hom.: 0 AF XY: 0.00427 AC XY: 91AN XY: 21336
GnomAD3 exomes
AF:
AC:
152
AN:
37246
Hom.:
AF XY:
AC XY:
91
AN XY:
21336
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000435 AC: 492AN: 1131814Hom.: 0 AF XY: 0.000531 AC XY: 290AN XY: 546038
GnomAD4 exome
AF:
AC:
492
AN:
1131814
Hom.:
AF XY:
AC XY:
290
AN XY:
546038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 150788Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73672
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
150788
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
73672
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Primary dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Genetics and Genomics Program, Sidra Medicine | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 08, 2022 | Variant summary: SGCB c.21_23delGGC (p.Ala9del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele was found at a frequency of 0.0041 in 37246 control chromosomes (gnomAD). The observed variant frequency is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in SGCB causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive phenotype (0.001), strongly suggesting that the variant is benign. c.21_23delGGC has been reported in the literature as a VUS (zygosity not specified) in settings of multigene panel testing in at-least one individual affected dilated cardiomyopathy without evidence for causality (Al-Shafai_2020). This report does not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Autosomal Recessive. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at